Vimarsana
Biggest News Aggregation in the World

Page 8 - Pharma Analyst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Analyst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Analyst Today - Breaking & Trending Today

GlobalData : Dr. Reddy's focuses on differentiated portfolio in key therapy areas as part of India growth strategy, says GlobalData - Vimarsana News

GlobalData : Dr. Reddy's focuses on differentiated portfolio in key therapy areas as part of India growth strategy, says GlobalData

24 Mar, 2023 Dr. Reddy's focuses on differentiated portfolio in key therapy areas as part of India growth strategy, says GlobalData Share ... | March 24, 2023

New RSV therapies may drive emergence of drug-resistant strains: Report - Vimarsana News

New RSV therapies may drive emergence of drug-resistant strains: Report

Despite their benefits, new therapies for respiratory syncytial virus (RSV) may accelerate the emergence of drug-resistant strains, according to a new report on Monday.Given the large market potential and high unmet need for new RSV therapies, ...

New RSV Therapies May Drive Emergence Of Drug-resistant Strains: Report - Vimarsana News

New RSV Therapies May Drive Emergence Of Drug-resistant Strains: Report

New York, March 13 (IANS) Despite their benefits, new therapies for respiratory syncytial virus (RSV) may accelerate the emergence of drug-resistant strains,

India's 1st homegrown mRNA Covid vax may have low market penetration: Report - Vimarsana News

India's 1st homegrown mRNA Covid vax may have low market penetration: Report

The recently approved Pune-based Gennova Biopharmaceuticals' two-dose mRNA Covid-19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report on Monday.The jab ...

SII's HPV vaccine to improve affordability for those most in need: GlobalData - Vimarsana News

SII's HPV vaccine to improve affordability for those most in need: GlobalData

The affordable vaccine will significantly improve the overall penetration and help address the growing number of cervical cancer